Exploring Psilocybin’s Potential in Anorexia Nervosa

🗣 Kate Godfrey (Imperial College London), Hannah Douglass (Imperial College London), Elinor Davies (Trial Participant), Katharine Lazenby (Trial Participant)

⏰ Thursday 1 February, 8PM CET (7PM GMT, 2PM EST, 11AM PST)

📍Online (OPEN Community Platform)

Exploring Psilocybin’s Potential in Anorexia Nervosa

Researchers at Imperial College London have completed an early phase clinical trial to assess the feasibility and preliminary outcomes of treating Anorexia Nervosa with psilocybin-assisted therapy. The pilot study (as yet, unpublished) seeks to sharpen the research focus and evaluate the utility and acceptability of study methods for implementation in a larger-scale study. Post-doctoral researcher, Kate Godfrey, and PhD student, Hannah Douglass, will be in conversation with two research participants, Elinor Davies and Katharine Lazenby, about the trial, their experiences and future research directions. This is an excellent opportunity to learn about a novel application of psychedelics and hear from trial participants about how psilocybin has impacted them.

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

Unlock access to this and all exclusive events with leading psychedelic experts and engage in real time through the OPEN Community Membership. Plus, enjoy a community space, a content library, discounts, and more.

ATTEND WITH A SMALL DONATION

Not ready to become an OPEN community member? You can attend this event through a small one-time donation to help support the OPEN Foundation, a leading nonprofit dedicated to advancing psychedelic research since 2007.

Really want to attend but can’t afford a donation? Apply for a one-time free access here.

ABOUT THE SPEAKERS

Kate Godfrey

Kate is a post-doctoral researcher passionate about novel treatments for mental health conditions and using neuroimaging to elucidate the mechanisms underlying response. She currently works at the Centre for Psychedelic research at Imperial College London where she oversees the implementation and analysis of a variety of neuroimaging modalities in currently ongoing psychedelic research studies.

Hannah Douglass

Hannah is a PhD Student at the Centre for Psychedelic Research, where she is supervised by Dr Robin Carhart-Harris, Dr Meg Spriggs and Dr David Erritzoe. She was awarded the President’s PhD Scholarship to investigate the feasibility and efficacy of psilocybin as a treatment for anorexia nervosa. Her research interests also include the enhancement of long-term potentiation, cognitive flexibility and interoceptive awareness by psychedelics. Prior to commencing her PhD, she received an MSc in Translational Neuroscience from Imperial College London and a BSc in Pharmacology from the University of Leeds.

Elinor Davies

Elinor was a research participant on the Panorexia Trial and is an expert by experience. She describes herself as a Christian, music and outdoor loving Welsh girl living and teaching in London.

Katharine Lazenby

Katharine was a research participant on the Panorexia Trial and is an expert by experience.

WHAT'S UNIQUE ABOUT THIS EVENT?

Attending this online event is an interactive experience, unlike watching a lecture on YouTube or a webinar. You'll have the chance to connect with the speakers directly and ask questions, allowing you to explore the topic in greater depth.

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

ATTEND WITH A SMALL DONATION

Really want to attend but can’t afford a donation? Apply for a one-time free access here.

ALREADY A MEMBER?

To access the OPEN Community Platform, click the button below. The platform not only live streams all events, but also provides direct access to event recordings.